RARE vs RMBI · rev $350.0M vs P/E 16, rev $43.1M
Ultragenyx (RARE) versus Richmond Mutual Bancorporation Inc (RMBI) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Richmond Mutual Bancorporation Inc (RMBI) is a banks - regional company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported RMBI revenue for 2026-06-30 was $43.1M. Net income was $5.0M. RMBI currently screens at market cap $146.2M and trailing P/E 15.8.
RARE currently screens at market cap $2.79B. RMBI currently screens at market cap $146.2M and trailing P/E 15.8.
Not investment advice. Open the RARE and RMBI stock pages for the full models.
Not investment advice.